Topical tacrolimus for the treatment of localized, idiopathic, newly diagnosed pyoderma gangrenosum

Journal of Dermatological Treatment

Volumn 21, Issue 3, 2010, Pages 140-143

  Marzano, Angelo Valerio ^a   Trevisan, Valentina ^a   Lazzari, Riccardo ^a   Crosti, Carlo ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Localized pyoderma gangrenosum; Pyoderma gangrenosum; Topical tacrolimus

Indexed keywords

TACROLIMUS;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DRUG DOSE REDUCTION; FEMALE; HUMAN; PRIORITY JOURNAL; PYODERMA GANGRENOSUM; RELAPSE; REMISSION;

ADMINISTRATION, TOPICAL; ADOLESCENT; ADULT; AGED; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; EARLY DIAGNOSIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MIDDLE AGED; PYODERMA GANGRENOSUM; RETROSPECTIVE STUDIES; SAMPLING STUDIES; SEVERITY OF ILLNESS INDEX; TACROLIMUS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77951111787     PISSN: 09546634     EISSN: 14711753     Source Type: Journal    
DOI: 10.3109/09546630903268239     Document Type: Article

References (17)

1. Crowson AN, Mihm MC Jr, Magro C. Pyoderma gangrenosum: A review. J Cutan Pathol. 2003;30(2):97-107.
2. Marzano AV, Tourlaki A, Alessi E, Caputo R. Widespread idiopathic pyoderma gangrenosum evolved from ulcerative to vegetative type: A 10-year history with a recent response to infliximab. Clin Exp Dermatol. 2008;33:156-159.
3. Marzano AV, Trevisan V, Galloni C, Alessi E. Fatal bullous pyoderma gangrenosum in a patient with Klinefelter's syndrome. Acta Derm Venereol. 2008;88(2):158-159.
4. Gupta AK, Adamiak A, Chow M. Tacrolimus: A review of its use for the management of dermatoses. J Eur Acad Dermatol Venereol. 2002;16(2):100-114.
5. Michel G, Kemeny L, Homey B, Ruzicka T. FK506 in the treatment of inflammatory skin disease: Promises and perspectives. Immunol Today. 1996;17(3):106-108.
6. Schuppe HC, Homey B, Assmann T, Martens R, Ruzicka T. Topical tacrolimus for pyoderma gangrenosum. Lancet. 1998; 351:832.
7. Ghislain PD, De Decker I, Lachapelle JM. Efficacy and systemic absorption of topical tacrolimus used in pyoderma gangrenosum. Br J Dermatol. 2004;150(5):1052-1053.
8. Jolles S, Niclasse S, Benson E. Combination oral and topical tacrolimus in therapy-resistant pyoderma gangrenosum. Br J Dermatol. 1999;140(3):564-565.
9. Lally A, Hollowood K, Bunker CB, Turner R. Penile pyoderma gangrenosum treated with topical tacrolimus. Arch Dermatol. 2005;141(9):1175-1176.
10. Khurrum Baig M, Marquez H, Nogueras JJ, Weiss EG, Wexner SD. Topical tacrolimus (FK506) in the treatment of recalcitrant parastomal pyoderma gangrenosum associated with Crohn's disease: Report of two cases. Colorectal Dis. 2004;6(4):250-253.
11. Kontos AP, Kerr HA, Fivenson DP, Remishofsky C, Jacobsen G. An open-label study of topical tacrolimus ointment 0.1% under occlusion for the treatment of pyoderma gangrenosum. Int J Dermatol. 2006;45(11):1383-1385.
12. Reich K, Vente C, Neumann C. Topical tacrolimus for pyoderma gangrenosum. Br J Dermatol. 1998; 139(4):755-757.
13. Vidal D, Alomar A. Successful treatment of periostomal pyoderma gangrenosum using topical tacrolimus. Br J Dermatol. 2004;150(2):387-388.
14. Lyon CC, Stapleton M, Smith AJ, Mendelsohn S, Beck MH, Griffiths CE. Topical tacrolimus in the management of peristomal pyoderma gangrenosum. J Dermatolog Treat. 2001; 12(1):13-17.
15. Chiba T, Isomura I, Suzuki A, Morita A. Topical tacrolimus therapy for pyoderma gangrenosum. J Dermatol. 2005; 32(3):199-203.
16. Kimble RM, Tickler AK, Nicholls VS, Cleghorn G. Successful topical tacrolimus (FK506) therapy in a child with pyoderma gangrenosum. J Pediatr Gastroenterol Nutr. 2002; 34(5):555-557.
17. Pitarch G, Torrijos A, Mahiques L, Sanchez-Carazo JL, Fortea JM. Systemic absorption of topical tacrolimus in pyoderma gangrenosum. Acta Derm Venereol. 2006; 86(1):64-65.